USO 24063
A Phase 2 Multiple-Dose, Multiple-Arm, Parallel Assignment Study to evaluate the Safety, Tolerability, and Preliminary Efficacy of XmAb20717 Alone or in Combination with Chemotherapy or Targeted Therapies in Selected Subjects with Metastatic Castration-Resistant Prostate Cancer (XmAb20717-04)
Disease Types: Genitourinary Cancer Research
Available at: